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Lepidium sativum is widely used in folk medicine for treatment of hyperactive airways disorders, such as asthma, bronchitis and
cough. The crude extract of Lepidium sativum (Ls.Cr) inhibited carbachol (CCh, 1μM-) and K+ (80mM-) induced contractions
in a pattern similar to that of dicyclomine. Ls.Cr at 0.03mg/mL produced a rightward parallel shift of CCh curves, followed by
nonparallel shift at higher concentration (0.1mg/mL), suppressing maximum response, similar to that caused by dicyclomine.
Pretreatment of tissues with Ls.Cr (0.1–0.3mg/mL) shifted Ca++ concentration-response curves (CRCs) to right, as produced
by verapamil. Ls.Cr at low concentrations (0.03–0.1mg/mL) caused leftward shift of isoprenaline-induced inhibitory CRCs, like
that caused by rolipram, a phosphodiesterase (PDE) inhibitor. These results indicate that bronchodilatory eﬀect of Lepidium
sativum is mediated through a combination of anticholinergic, Ca++ antagonist and PDE inhibitory pathways, which provides
sound mechanistic background for its medicinal use in the overactive airways disorders.
1.Introduction
Most of the disorders of respiratory system results from the
hyperactivity of airways. Asthma is a major congestive respi-
ratory disorder, characterized by episodic wheezing, cough,
and chest tightness, associated with airﬂow obstruction. The
worldwide prevalence of asthma has been increasing par-
ticularly in children. According to the World Health Orga-
nization, it aﬀects about 5–10% of adults and 10% of
children globally [1]. Cough is a spasmodic contraction of
the thoracic cavity that results in abrupt release of air from
the lungs. Excessive cough is one of the most common
symptoms for which the patients seek medical care and may
represent up to one-third of a pulmonologist’s outpatient
practice referrals [2].
The conventional therapy for these congestive airways
disorders particularly asthma is not always safe, eﬃcacious
and is beyond the access and/or aﬀordability of large
proportion of world population, who look for alternative
therapeutic measures. Phytotherapy is the most popular
alternative remedy, and a number of traditional systems of
medicineareheavilybasedontheuseofherbsasmedicine[3,
4]. At the same time, there is a global revival of interest in the
use of botanicals, and the physicians of the modern medicine
are now beginning to accept the traditional remedies once
they are scientiﬁcally validated [5, 6].
Lepidium sativum Linn. belongs to family Cruciferae
(cabbage family) and is commonly known as “Common
cress,” “Garden cress,” or “Halim.” The plant is called “Hab
el Rashaad” or “Thufa” in Saudi Arabia and is a popular
herbal plant grown in many regions of Saudi Arabia, such
as Hijaz, AL-Qaseem, and the Eastern Province [7, 8]. In
Europe and America, the leaves are used in salad. In various
countriesof Africa,Lepidiumsativum seedsarethoughttobe
an eﬀective medicinal remedy to cure respiratory disorders,
like bronchitis and asthma [9]. The plant is cultivated as2 Evidence-Based Complementary and Alternative Medicine
culinary vegetable all over Asia [10]. In South Asia, it is
used in traditional medicine to treat asthma, bronchitis, and
cough and is considered useful as abortifacient, antibacterial,
aphrodisiac,diuretic,expectorant,gastrointestinalstimulant,
gastroprotective, laxative, and stomachic [11, 12].
The plant is known to contain imidazole, lepidine,
semilepidinoside A and B [13], β-carotenes, ascorbic acid,
linoleic acid, oleic acid, palmitic acid, stearic acid [14],
sinapic acid and sinapin [15]. Lepidium sativum is re-
ported to exhibit antihypertensive [16], diuretic [17], anti-
inﬂammatory, analgesic, anticoagulant [18], antirheumatic
[19], hypoglycemic [20], laxative, prokinetic [21], antidiar-
rheal, and antispasmodic [22] properties. It has been shown
to possess antiasthmatic [23] and bronchodilatory [24]
potential in preliminary studies, but there is no report
available in the literature on the pharmacological basis for
its medicinal use in airways disorders. In this study, we
explored the possible mechanisms underlying its airways
relaxant eﬀect, mediated through multiple pathways, includ-
ing inhibitory eﬀect on muscarinic receptors, Ca++ channels
and phosphodiesterase (PDE) enzyme; thus, this study pro-
vides sound pharmacological rational for its eﬀectiveness in
the airways hyperactive disorders.
2.MaterialsandMethods
2.1. Plant Material and Extraction. Seeds of Lepidium
sativum were purchased from herbal store (Bin Menqash,
Riyadh,SaudiArabia)inMarch,2010.Theplantwasauthen-
ticated by Dr. Mohammed Yusuf, King Saud University,
and the specimen has been preserved at the herbarium of
the College of Pharmacy, King Saud University, Riyadh,
Saudi Arabia and also at Natural Product Research Unit,
Department of Biological and Biomedical Sciences, Aga
Khan University, Karachi with voucher no. Ls-SE-04-10-98.
The Lepidium sativum seeds were soaked in 70% methanol
for three days [25] and then ﬁltered through muslin cloth
and Whatman ﬁlter paper (Maidstone, UK). This procedure
was repeated three times, and all the ﬁltrates were pooled
and evaporated on rotary evaporator (model RE-111, Buchi,
Flawil, Switzerland) under reduced pressure (−760mm Hg)
to obtain the crude extract of Lepidium sativum (Ls.Cr),
yielding approximatly 15%.
2.2. Chemicals and Animals. Atropine sulphate, carbachol
(CCh), dicyclomine, isoprenaline, verapamil, and rolipram
were purchased from Sigma Chemicals Company, St. Louis,
MO, USA. Guinea-pigs (500–550g) of either sex and local
breed were kept at the Animal House of the Aga Khan
University, maintained at 23–25◦C, and were given standard
diet and tap water. Experiments were performed in compli-
ance with the rulings of the Institute of Laboratory Animal
Resources, Commission on Life Sciences, National Research
Council [26] and approved by Ethical Committee of the Aga
Khan University.
2.3. Guinea-Pig Trachea. Tracheal ring strips obtained from
guinea-pigs sacriﬁced by cervical dislocation were mounted
individually in 20mL tissue bath containing Kreb’s solution,
at 37◦C and aerated with carbogen. A tension of 1g was ap-
pliedtoeachofthetissuesandequilibratedfor1hrbeforethe
additionofanydrug.Carbachol(1μM)andK+0020(80mM)
were used to induce sustained contractions, and relaxant
activityofcrudeextractwasassessedbyaddingincumulative
fashion. High K+ (>30mM) is known to cause smooth
muscle contractions through opening of voltage-dependent
L-type Ca++ channels, thus allowing inﬂux of extracellular
Ca++ causing a contractile eﬀect and the substance causing
inhibition of high K+-induced contraction is considered
as inhibitor of Ca++ inﬂux [27, 28]. The antimuscarinic
eﬀect of plant extract was investigated through constructing
CCh-concentration-response curves (CRCs) in its presence
[29]. The Ca++ channel blockade (CCB) eﬀect of test sub-
stance was conﬁrmed via building Ca++-CRCs in the Ca++-
free medium [28]. The presence of PDE inhibitory eﬀect
was evaluated indirectly through constructing isoprenaline-
induced inhibitory CRCs against CCh-induced contractions
in absence and presence of plant material, as described
previously [30]. Isometric responses were recorded on a
Grass model 7 Polygraph (Grass Instrument Company,
Quincy, MA, USA).
2.4. Statistical Analysis. The median eﬀective concentrations
(EC50) with 95% conﬁdence intervals (CIs) are provided.
CRCs wereanalyzedbynonlinear regressionusingGraphPad
program (GraphPAD, San Diego, CA, USA).
3. Results
3.1. Inhibitory Eﬀect of Ls.Cr on CCh and High K+-Induced
Contractions. When tested against CCh (1μM-) and K+
(80mM-) induced contractions, Ls.Cr inhibited the CCh-
induced contractions at lower concentration with EC50 value
of 0.32mg/mL (0.30–0.44, 95% CI), compared to its eﬀect
against K+ (80mM) with EC50 value of 5.4mg/mL (4.3–7.2)
as shown in Figure 1(a). Dicyclomine also showed a similar
pattern of inhibitory eﬀect (Figure 1(b))w i t hr e s p e c t i v e
EC50 values of 0.28μM (0.20–0.40) and 4.6μM (3.0–7.2),
whereas verapamil was more potent against K+-induced
contractions with EC50 value of 0.14μM (0.10–0.20), when
compared with CCh-induced contractions (2.7μM (1.7–
3.5)) as shown in Figure 1(c). Atropine only relaxed the CCh
(1μM-) induced contraction, with EC50 value of 0.006μM
(0.002–0.01), without any eﬀect on K+ (80mM-) induced
contractions (Figure 1(d)), as expected.
3.2. Eﬀect of Ls.Cr on CCh Curves. Pretreatment of the
tissues with Ls.Cr at 0.03mg/mL caused rightward parallel
shift of CCh curves, without suppression of maximum
contractileresponse,followedbyanon-parallelshiftwiththe
s u p p r e s s i o no fm a x i m u mr e s p o n s ea tn e x th i g h e rc o n c e n -
tration,0.1mg/mL(Figure 2(a)).Dicyclomine(0.03-0.1μM)
also showed a similar pattern of shift (Figure 2(b)), while
verapamil (0.1–0.3μM) produced a nonparallel rightward
shift at both tested concentration with suppression of the
maximum response (Figure 2(c)). Atropine (0.01–0.03μM)Evidence-Based Complementary and Alternative Medicine 3
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Figure1:Concentration-responsecurvesshowingcomparison(a)crudeextractofLepidiumsativum(Ls.Cr),(b)dicyclomine,(c)verapamil,
and (d) atropine for the inhibitory eﬀect against carbachol (CCh) and high K+-induced contractions in isolated guinea-pig tracheal
preparations, n = 3–5.
causedrightwardparallelshiftwithoutthesuppressionofthe
maximum contractile eﬀect (Figure 2(d)).
3.3. Eﬀect of Ls.Cr on Ca++ Curves. When tested for the pos-
sible interaction with Ca++ channels, Ls.Cr (0.1–0.3mg/mL)
produced rightward shift in the Ca++ curves (Figure 3(a)),
similar to that caused by verapamil (Figure 3(b)).
3.4. Eﬀect of Ls.Cr on Isoprenaline Curves. Pretreatment of
tissues with Ls.Cr at low concentrations (0.03–0.1mg/mL)
shifted the isoprenaline-induced inhibitory CRCs to the left
(Figure 4(a)), showing potentiating eﬀect. Rolipram (0.3–
1.0μM) also caused similar leftward shift of the isoprenaline
curves,asshowninFigure 4(b).Dicyclomine,verapamil,and
atropine were found devoid of such eﬀect (data not shown).4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Concentration-response curves of carbachol (CCh) in the absence and presence of diﬀerent concentrations of (a) crude extract of
Lepidium sativum (Ls.Cr), (b) dicyclomine, (c) verapamil, and (d) atropine in isolated guinea-pig tracheal preparations, n = 3-4.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Concentration-response curves of Ca++ in the absence and presence of the increasing concentrations of (a) crude extract of
Lepidium sativum (Ls.Cr) and (b) verapamil in isolated guinea-pig tracheal preparations, n = 3-4.
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Figure 4: Inhibitory concentration-response curves of isoprenaline against carbachol (CCh)-induced contractions in the absence and
presence of diﬀerent concentrations of (a) crude extract of Lepidium sativum (Ls.Cr) and (b) rolipram in isolated guinea-pig tracheal
preparations, n = 3. The curves obtained by pretreatment of tissues with Ls.Cr and rolipram are signiﬁcantly diﬀerent from the respective
isoprenaline control curves (P<0.05), Student’s t-test.6 Evidence-Based Complementary and Alternative Medicine
4. Discussion
In view of the medicinal use of Lepidium sativum in the hy-
peractive airways disorders, its aqueous-methanol extract
was tested for the possible bronchodilatory eﬀect. In guinea-
pig tracheal preparations, plant extract inhibited the CCh-
and high K+-induced contractions, being more potent
against CCh. Dicylomine, a dual blocker of muscarinic
receptors and Ca++ inﬂux [31], showed a similar pattern
of inhibition, while verapamil, a standard Ca++ antagonist
[32], was more potent against the K+-induced contractions
than those induced by CCh, while atropine, a muscarinic
receptor antagonist [33], relaxed the CCh-induced contrac-
tions only. It is thereby suggesting the inhibitory eﬀect on
muscarinic receptor and Ca++ channels. The presence of
anticholinergic and CCB actions was further conﬁrmed,
respectively, through constructing the CCh and Ca++ CRCs
in the presence of diﬀerent concentrations of the plant
extract. A parallel displacement of CCh curves without
suppression of the maximum eﬀect was observed at the
lowerconcentrationofLs.Cr,acharacteristicofacompetitive
or speciﬁc antagonist, like atropine [34], followed by non-
parallel shift with suppression of the maximum eﬀect at
higher concentration, pointing towards the presence of
nonspeciﬁc inhibition, like known with Ca++ antagonists
[35]. Dicyclomine also shifted the CCh curves to the right,
similar to that of the crude extract, while verapamil resulted
in rightward but non-parallel shift with suppression of the
maximum eﬀect at both the concentrations used. Atropine
caused a rightward parallel shift of the CCh curves without
suppression of maximum response. Pretreatment of tissues
with Ls.Cr shifted the Ca++ curves to the right accompanied
by the suppression of maximum response, similar to that
causedbyverapamil,conﬁrmingtheCa++ antagonisticeﬀect.
Wehaveexperiencedthatplantswithmedicinaluseinthe
overactive airways disorders usually possess PDE inhibitory
eﬀect, which usually coexists with Ca++ antagonist activity
[30, 36, 37]. To investigate whether Lepidium sativum also
exhibits PDE enzyme inhibition component(s), isoprenaline
inhibitory CRCs were constructed against CCh-induced
contractions by pretreatment of tissues with Ls.Cr, as PDE
inhibitors are known to potentiate the isoprenaline eﬀect
[38]. The presence of PDE inhibitory eﬀect in Lepidium
sativum was conﬁrmed when the plant extract potenti-
ated isoprenaline relaxant eﬀect, by causing leftward shift
of isoprenaline-induced inhibitory curves, similar to that
caused by rolipram, a PDE4 inhibitor, predominant enzyme
in airways [39]. These ﬁndings indicate that bronchodilator
eﬀect of Lepidium sativum is mediated through combined
anticholinergic, CCB, and PDE inhibitory pathways; thus,
this study provides sound mechanistic basis for its appli-
cation in airways hyperactivity disorders. The usefulness of
anticholinergics and PDE inhibitors in asthma is well estab-
lished [40], though major limitation is cardiac stimulation,
as a side-eﬀect when applied orally [41, 42]. Interestingly,
Ca++ antagonists are also useful in bronchoconstriction [43]
and are known to exhibit cardiosuppressant eﬀect [44].
The coexistence of CCB constituent(s) with antimuscarinic
and PDE inhibitors in Lepidium sativum is perhaps meant
by nature to oﬀset the tachycardia, usually associated with
anticholinergics or PDE inhibitors when used alone. This
scenario strengthens the concept that natural remedies
possess “eﬀect enhancing and/or side-eﬀects neutralizing”
potential in addition to cost-eﬀectiveness and oﬀers merit in
evidence-based studies [6, 45].
In conclusion, these results show that Lepidium sativum
oﬀers a unique combination of bronchodilator activi-
ties (anticholinergic, Ca++ antagonist and PDE inhibitory
eﬀects), which may explain its medicinal use in the hyperac-
tive airways disorders, such as cough and asthma. However,
further in-depth studies are required to probe nature of
chemicals constituents and molecular base of biological
activities.
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